Ann: US patent granted for IMP701 antibody, page-69

I can't tell you morbidity as cancer is caused by multiple things going haywire and stage 3. Nowadays pharma likes to skip stage 2 and reclassify as stage 2a/3 or 2b/3 to facilitate possible treatments. In terms of locations, it is multisite and countries. As to the rest, it will be silly for me to tell too much in the advent that some pharma peepz looking at this post and raise a red flag. Take it with a grain a salt since science is always changing. It may not be the case in another 5 years time. Who knows. But you can certainly look up pubmed for your own research.